ehealth digital library

Digital library of
the Tanzania
health
community

Experience and Challenges from Clinical Trials with Malaria Vaccines in Africa.

Mwangoka, G., Ogutu, B., Msambichaka, B., Mzee, T., Salim, N., Kafuruki, S., Mpina, M., Shekalaghe, S., Tanner, M. and Abdulla, S. (2013) Experience and Challenges from Clinical Trials with Malaria Vaccines in Africa. Malaria journal, 12. p. 86. ISSN 1475-2875

[img]
Preview
PDF
Grace_Mwangoka.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (233kB)

Abstract

Malaria vaccines are considered amongst the most important modalities for potential elimination of malaria disease and transmission. Research and development in this field has been an area of intense effort by many groups over the last few decades. Despite this, there is currently no licensed malaria vaccine. Researchers, clinical trialists and vaccine developers have been working on many approached to make malaria vaccine available.African research institutions have developed and demonstrated a great capacity to undertake clinical trials in accordance to the International Conference on Harmonization-Good Clinical Practice (ICH-GCP) standards in the last decade; particularly in the field of malaria vaccines and anti-malarial drugs. This capacity is a result of networking among African scientists in collaboration with other partners; this has traversed both clinical trials and malaria control programmes as part of the Global Malaria Action Plan (GMAP). GMAP outlined and support global strategies toward the elimination and eradication of malaria in many areas, translating in reduction in public health burden, especially for African children. In the sub-Saharan region the capacity to undertake more clinical trials remains small in comparison to the actual need.However, sustainability of the already developed capacity is essential and crucial for the evaluation of different interventions and diagnostic tools/strategies for other diseases like TB, HIV, neglected tropical diseases and non-communicable diseases. There is urgent need for innovative mechanisms for the sustainability and expansion of the capacity in clinical trials in sub-Saharan Africa as the catalyst for health improvement and maintained.

Item Type: Article
Keywords: Malaria, Vaccines, Clinical Trials, Experiences, Challenges, Africa
Subjects: Malaria > Vaccines
Divisions: Ifakara Health Institute > Biomedical
Depositing User: Mr Joseph Madata
Date Deposited: 16 May 2013 07:17
Last Modified: 16 May 2013 07:17
URI: http://ihi.eprints.org/id/eprint/1418

Actions (login required)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics